ALLAN C SILBER

CIK 1009161 · Executive Chairman · last filed 2023-12-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.57M

Companies

3

Total Filings

35

Lifetime Open-Market Net

-$2.20M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
POINT Biopharma Global Inc. (PNT) Delisted Executive Chairman 4,268,605 $12.50 $53.36M $311.2K 5 2023-12-27
HGBL 10%+ Owner 3,598,215 $1.27 $4.57M -$2.51M 7 2021-09-03
POINT Biopharma Global Inc. (RACA) Delisted Director 8,254,260 $10.27 $84.81M $0 1 2021-06-30

Recent Filings · Page 2 of 4

35 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-07-02 HGBL Sell (S) −681 -$1.7K EDGAR
2021-06-30 POINT Biopharma Global Inc. (RACA) Delisted Grant (A) +8,864,091 $0 EDGAR
2021-05-11 HGBL Mixed −538,855 -$1.79M EDGAR
2020-04-06 Grant (A) $0
2019-04-02 Grant (A) $0
2018-04-02 Grant (A) $0
2017-04-04 Grant (A) $0
2017-01-03 Buy (P) +2,928,462 $1.43M
2016-12-12 Grant (A) $0
2016-04-01 Grant (A) $0
Showing 1120 of 35
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.